Dr. Gerald Diaz @GeraldMD
25.7M 13.9K 7.3K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
9 results
management anticoagulation venous doac thromboembolism cancer dvt longterm malignancy thrombosis carcinoma chemotherapy cyp3a4 embolism gastroenterology hcc hepatocellular hepatology inducers inhibitors
Venous Thromboembolism Treatment Algorithm Branch points: Active bleeding? Active malignancy? Provoked? - Dr. Joseph Shatzel @Clotmaster #Management #VTE #DVT
Thromboembolism Treatment ... Algorithm Branch ... #Management #VTE ... #DVT #Algorithm ... #Hematology #Anticoagulation
Treatment Algorithm for First Time DVT • Provoked • Unprovoked • Active Malignancy By Carlin Rooke, MD. #DVT
Treatment Algorithm ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE
Treatment Algorithm for First Time Pulmonary Embolism • Provoked • Unprovoked • Active Malignancy By Carlin Rooke,
Treatment Algorithm ... Pulmonary #Embolism #Treatment ... #Algorithm #management ... #hematology #VTE
Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... risk of recurrent VTE ... Anticoagulation #Management #Hematology ... #Oncology
Algorithm for the Long-Term Treatment of Venous Thromboembolism Reference: https://doi.org/10.1182/blood.2019002364 by Dr. Clive Kearon and Dr. Susan
Algorithm for the ... Long-Term Treatment ... #LongTerm #Treatment ... Thromboembolism #VTE ... #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #Cancer #Algorithm ... Anticoagulation #Management #Hematology ... #Oncology
►
 (DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline First Line Treatment for HCC with Preserved
First Line Treatment ... Function Second Line Treatment ... #Management #Hepatology ... Gastroenterology #oncology ... #Pharmacology
Longterm Venous Thromboembolism Treatment Algorithm Treat for 3 months and reassess • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
empty